INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined garlic. Clear

Pooled results from many studies on one question.

3 studies

2019 / Systematic review and meta-analysis

In patients with diabetes, garlic intake significantly improved lipid parameters, fasting blood sugar, and HbA1C compared to placebo.

A systematic review and meta-analysis of 33 studies evaluated the effects of garlic compared with placebo in 1,273 individuals with diabetes. Garlic was associated with significant decreases in total cholesterol by 16.87 mg/dl (95% CI, -21.01 to -12.73; P=0.001), LDL by 9.65 mg/dl (95% CI, -15.07 to -4.23; P=0.001), triglycerides by 12.44 mg/dl (95% CI, -18.19 to -6.69; P=0.001), fasting blood sugar by 10.90 mg/dl (95% CI, -16.40 to -5.40; P=0.001), and HbA1C by 0.60 mg/dl (95% CI, -0.98 to -0.22; P=0.001). Serum HDL significantly increased by 3.19 mg/dl (95% CI, 1.85 to 4.53; P=0.001).

Shabani E, Sayemiri K, Mohammadpour M Prim Care Diabetes, 2019. PMID 30049636

2018 / Systematic review

Evidence for superfood effects on metabolic syndrome risk factors remains limited

A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.

van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436

2014 / Meta-analysis of randomized controlled clinical trials

Garlic powder supplementation significantly reduced total cholesterol, LDL-C, fasting blood glucose, and blood pressure in randomized clinical trials.

A meta-analysis evaluated randomized controlled trials investigating the effects of garlic powder intake on cardiovascular disease risk factors. Garlic powder intake significantly reduced total cholesterol by -0.41 mmol/L (-15.83 mg/dL) and LDL-C by -0.21 mmol/L (-8.11 mg/dL). It also lowered fasting blood glucose by -0.96 mmol/L (-17.30 mg/dL), systolic blood pressure by -4.34 mmHg, and diastolic blood pressure by -2.36 mmHg.

Kwak JS, Kim JY, Paek JE, et al. Nutr Res Pract, 2014. PMID 25489404